/TFFP

TFFP Stock - TFF Pharmaceuticals, Inc.

Q: What is the analyst price target for TFFP?

Analyst price target information is not currently available for TFFP.

Q: What is TFFP's market cap?

Market capitalization information is not currently available for TFFP.

Healthcare|Biotechnology|NASDAQ

$0.07-60.05%

$0.10 (-60.05%) • Dec 12

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.07

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TFFP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.32

52W High$11.00

52W Low$0.06

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$733,871	N/A	N/A	N/A	N/A
Gross Profit	$231,391	$-388,221	$-111,453	N/A	N/A
Gross Margin	31.5%	N/A	N/A	N/A	N/A
Operating Income	$-21,894,662	$-31,796,790	$-31,786,658	$-18,693,650	$-11,987,557
Net Income	$-21,243,231	$-31,770,035.272	$-30,987,480	$-18,440,818	$-11,752,899
Net Margin	-2894.7%	N/A	N/A	N/A	N/A
EPS	$-11.85	$-26.49	$-31.21	$-22.57	$-42.55

Company Overview

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

1 Bullish0 Neutral/Bearish

Price Targets

$22

Average Target

↑ 33746.2% Upside

Now

$22

Low

$22

Average

$22

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
May 19th 2022	H.C. Wainwright	Resumed	Buy	$22

Earnings History & Surprises

TFFP

Beat Rate

53%

Last 19 quarters

Avg Surprise

-2.4%

EPS vs Estimate

Beats / Misses

10/8

1 met exactly

Latest EPS

$-0.81

Q4 2024

EPS Surprise History

Q1 23

+58.3%

$-0.10vs$-0.24

Q2 23

+5.0%

$-4.75vs$-5.00

Q3 23

+30.0%

$-3.50vs$-5.00

Q4 23

+18.2%

$-2.25vs$-2.75

Q1 24

-0.5%

$-2.01vs$-2.00

Q2 24

-9.1%

$-2.40vs$-2.20

Q3 24

+28.2%

$-1.22vs$-1.70

Q4 24

0.0%

$-0.81vs$-0.81

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2024	Nov 20, 2024	$-0.81	$-0.81	0.0%	= MET
Q3 2024	Aug 14, 2024	$-1.70	$-1.22	+28.2%	✓ BEAT
Q2 2024	May 14, 2024	$-2.20	$-2.40	-9.1%	✗ MISS
Q1 2024	Mar 28, 2024	$-2.00	$-2.01	-0.5%	✗ MISS
Q4 2023	Nov 14, 2023	$-2.75	$-2.25	+18.2%	✓ BEAT
Q3 2023	Aug 15, 2023	$-5.00	$-3.50	+30.0%	✓ BEAT
Q2 2023	May 11, 2023	$-5.00	$-4.75	+5.0%	✓ BEAT
Q1 2023	Mar 7, 2023	$-0.24	$-0.10	+58.3%	✓ BEAT
Q4 2022	Nov 14, 2022	$-7.75	$-7.25	+6.5%	✓ BEAT
Q3 2022	Aug 11, 2022	$-8.00	$-8.50	-6.3%	✗ MISS
Q2 2022	May 11, 2022	$-9.50	$-8.25	+13.2%	✓ BEAT
Q1 2022	Mar 24, 2022	$-7.50	$-10.00	-33.3%	✗ MISS
Q4 2021	Nov 15, 2021	$-3.50	$-8.50	-142.9%	✗ MISS
Q3 2021	Aug 12, 2021	$-7.00	$-4.50	+35.7%	✓ BEAT
Q2 2021	May 13, 2021	$-6.00	$-8.25	-37.5%	✗ MISS
Q1 2021	Mar 10, 2021	$-5.75	$-6.50	-13.0%	✗ MISS
Q4 2020	Nov 5, 2020	$-5.00	$-6.00	-20.0%	✗ MISS
Q3 2020	Aug 13, 2020	$-5.25	$-5.00	+4.8%	✓ BEAT
Q2 2020	May 14, 2020	$-6.00	$-5.00	+16.7%	✓ BEAT
Q1 2020	Mar 26, 2020	—	$-50.00	—	—

Frequently Asked Questions about TFFP

What is TFFP's current stock price?

TFF Pharmaceuticals, Inc. (TFFP) is currently trading at $0.07 per share. The stock has moved -60.05% today.

What is the analyst price target for TFFP?

No analyst price targets are currently available for this stock.

What sector is TFF Pharmaceuticals, Inc. in?

TFF Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is TFFP's market cap?

TFF Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does TFFP pay dividends?

No, TFF Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.